Biodegradable PCL Spinal Cage with Calcium Phosphate Coating
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current spinal fusion cages, particularly metallic ones, face issues such as excessive rigidity leading to stress-shielding, migration, and complications like pseudoarthrosis, while degradable polymer cages struggle with maintaining mechanical stability and controlling acidic degradation products that can inhibit osteogenesis.
Innovation Solution
Development of a biodegradable spine fusion cage made from polycaprolactone (PCL) with a calcium phosphate mineral coating, designed using Solid Free-Form Fabrication techniques, which enhances osteoconductivity and provides a controlled release of therapeutic molecules like bone morphogenetic proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If metallic cages are used for spinal fusion, then mechanical stability and structural strength are improved, but stress-shielding and migration occur due to excessive rigidity
Solution Approach 1:
The patent changes the material parameters from metallic to biodegradable polymer (PCL), fundamentally altering the mechanical properties to reduce rigidity while maintaining adequate structural support. This parameter change resolves the stress-shielding problem by matching the implant's mechanical properties more closely to native bone, allowing physiological stress transmission while preventing migration through adequate initial stability.
2Object-affected harmful factors
If biodegradable polymer cages are used, then stress-shielding is reduced and bone grafting is improved, but mechanical stability deteriorates due to lower stiffness
Solution Approach 1:
The patent creates a composite structure by coating the PCL polymer cage with calcium phosphate mineral layers. This composite approach combines the advantages of both materials: the biodegradable polymer provides stress-shielding reduction and gradual resorption, while the mineral coating restores mechanical strength and provides osteoconductivity. The composite structure resolves the mechanical stability deficiency of pure polymer cages.
Solution Approach 2:
The patent employs a porous microstructure design in the PCL cage, which optimizes the balance between mechanical properties and biological functionality. The porous architecture provides adequate structural support while maintaining appropriate flexibility, and simultaneously facilitates bone ingrowth and material resorption. This porous design resolves the mechanical stability concern by optimizing the structural efficiency of the biodegradable polymer.
3Object-affected harmful factors
If degradable cages are used, then imaging artifacts are eliminated and bone fusion is enhanced, but acidic degradation products inhibit osteogenesis
Solution Approach 1:
The patent converts the potentially harmful acidic degradation products into a beneficial effect by buffering them against bone tissue. The calcium phosphate mineral coating acts as a buffer that neutralizes the acidic environment created during PCL degradation, preventing osteogenesis inhibition. This transforms the harmful acidic byproducts into a controlled resorption process that actually promotes bone formation by maintaining appropriate pH levels at the implant-bone interface.
4Strength
If metallic cages are used, then structural strength is maintained, but revision difficulty and adjacent level disc disease increase
Solution Approach 1:
The patent employs a biodegradable polymer cage that gradually resorbs over time, eliminating the need for surgical revision or removal. The PCL material is designed to degrade at a controlled rate, transferring load to the regenerating bone tissue and ultimately being completely resorbed. This resolves the revision difficulty problem by making the implant temporary and self-eliminating, while the calcium phosphate coating ensures adequate mechanical support is maintained throughout the degradation process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PCL cages with calcium phosphate coatings demonstrate improved mechanical stability, enhanced bioactivity, and effective delivery of bioactive agents, promoting bone fusion and reducing complications associated with traditional cages.
Implementation Method 1
enhances osteoconductivity and provides a controlled release of therapeutic molecules
Implementation Method 2
biodegradable polymer polycaprolactone (PCL)
Data Source
Figure 1A
Figure 1B
Figure 2
AI summary
A cage for facilitating fusion of bones, such as vertebrae, or fusion of adjacent bone surfaces is disclosed. In one form, the cage includes a plurality of spaced apart walls comprising a biodegradable polymeric material (e.g., polycaprolactone); an osteoconductive mineral coating (e.g., a calcium compound) on at least a portion of the walls; and a bioactive agent (e.g., a bone morphogenetic protein) associated with the polymeric material and/or the coating. The bioactive agent is present in amount that induces ossification between the bones or adjacent bone surfaces. The cage may also include a fixation plate connected to at least one of the walls.